Skip to main content
CAMP logo

Camp4 Therapeutics Corporation

CAMPNASDAQHealthcareBiotechnology

$3.21Today:- (-)1Y −2.59%

As of Oct 26, 2026 close

Market cap
$185.95M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$2.90$7.75
Volume (live)
-
Avg. volume (3M)
268.13K

Camp4 Therapeutics (CAMP) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Camp4 Therapeutics reported total assets of $117.81M and total liabilities of $70.10M. Shareholders' equity was $47.70M, down 24.5% from $63.14M a year earlier. Total debt stood at $1.97M against $109.52M in cash and short-term investments, a net cash position of $107.54M. That puts debt-to-equity at 0.04, compared with 0.09 a year earlier.

Camp4 Therapeutics Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for Camp4 Therapeutics Corporation (CAMP) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2023FY 2022FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Nov 2023Feb 2023Dec 2022Feb 2022Feb 2021Feb 2020Feb 2019Feb 2018
Current Assets
Cash and Cash Equivalents109.5264.0438.3838.3883.1983.1991.1191.69107.40256.50132.60
Short-Term Investments0.000.00-0.000.00-0.000.000.0017.5123.40
Cash & Short-Term Investments109.5264.0438.3838.3883.1983.1991.1191.69107.40274.01156.00
Accounts Receivable0.160.110.440.440.680.6858.5967.8572.2778.0871.58
Inventory0.000.00-0.000.00-20.1832.1636.7832.0336.30
Other Current Assets4.422.341.631.190.540.2123.7123.5221.4119.3712.00
Total Current Assets114.1066.3840.0140.0184.4184.41193.59215.23237.87403.50275.89
Non-Current Assets
Property, Plant & Equipment (Net)2.7410.3013.3113.3116.8016.8050.0662.2376.5027.0221.26
Long-Term Investments0.890.00-0.000.00-24.3424.160.004.918.84
Goodwill0.000.00-0.000.00-94.0094.47106.3480.8172.98
Intangible Assets0.000.00-0.000.00-33.0138.9445.9047.1752.46
Other Non-Current Assets0.081.621.621.621.351.353.052.3624.7717.609.99
Total Non-Current Assets3.7111.9214.9314.9318.1418.14208.70226.60257.94200.13197.11
Total Assets117.8178.3154.9554.95102.55102.55402.29441.82495.81603.63472.99
Current Liabilities
Accounts Payable0.181.211.041.042.152.1530.7836.8328.4539.9035.48
Short-Term Debt0.290.090.413.062.37-7.7410.9437.7836.8432.22
Current Portion of Long-Term Debt-0.090.41--------
Accrued Liabilities2.904.833.30--1.65-----
Deferred Revenue9.390.39-0.000.00-32.4038.9334.7024.2617.76
Other Current Liabilities5.660.180.293.713.430.2623.9618.2020.31-17.4110.08
Total Current Liabilities15.519.607.817.817.957.9594.88107.38121.4883.5995.53
Non-Current Liabilities
Long-Term Debt1.695.490.098.6410.0310.03201.43199.86201.37275.91154.30
Deferred Tax Liabilities0.000.00-0.000.00-0.216.970.120.96-16.76
Other Non-Current Liabilities44.790.070.00162.23162.11-0.0411.104.087.4738.4824.25
Total Non-Current Liabilities54.595.578.72170.87172.13172.13227.23235.12236.41314.38178.55
Total Liabilities70.1015.1616.53178.68180.08180.08322.11342.51357.89397.97274.08
Stockholders' Equity
Common Stock0.010.000.000.000.000.000.360.350.340.340.36
Retained Earnings-292.16-211.75-159.96-159.96-110.67-110.67-156.78-129.25-81.53-2.23-19.46
Accumulated Other Comprehensive Income0.000.00-0.000.00--2.44-1.11-1.38-0.66-0.20
Additional Paid-in Capital339.85274.9036.2336.2333.1433.14239.04229.33220.48208.21218.22
Shares Outstanding51.9020.1619.51--19.51-----
Total Stockholders' Equity47.7063.1438.42-123.73-77.53-77.5380.1899.32137.92205.65198.92
Total Liabilities & Equity117.8178.3154.9554.95102.55102.55402.29441.82495.81603.63472.99

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Camp4 Therapeutics Balance Sheet

How much debt does Camp4 Therapeutics have?

Camp4 Therapeutics had total debt of $1.97M as of Dec 31, 2025, against $109.52M in cash and short-term investments. Its debt-to-equity ratio was 0.04. Total debt was $5.58M a year earlier.

What are Camp4 Therapeutics's total assets?

Camp4 Therapeutics reported total assets of $117.81M as of Dec 31, 2025, up 50.4% from $78.31M a year earlier. Total liabilities were $70.10M.

What is Camp4 Therapeutics's shareholders' equity?

Camp4 Therapeutics's shareholders' equity was $47.70M as of Dec 31, 2025, or about $0.92 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition